文献速递眼底病与葡萄膜炎

非感染性后节葡萄膜炎中视觉功能反应与炎症减轻的关联

Association Between Visual Function Response and Reduction of Inflammation in Noninfectious Uveitis of the Posterior Segment.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

本研究为3期SAKURA研究1的事后分析,347例活动性非感染性后节葡萄膜炎受试者随机接受玻璃体内注射西罗莫司44μg、440μg或880μg每两月一次。玻璃体混浊反应(第5个月VH评分0或0.5+)与VFQ-25综合评分、心理健康子量表、BCVA及总体视觉功能反应均显著相关。

要点

  • 玻璃体混浊反应与VFQCS改善显著相关(OR=2.23;P=0.0004)
  • 玻璃体混浊反应与VFQMHS改善显著相关(OR=2.84;P<0.0001)
  • 玻璃体混浊反应与BCVA改善及总体视觉功能反应显著相关(OR分别为2.60和2.65)

核心结论

  • 炎症减轻至VH评分0或0.5+与视觉功能改善显著相关,达到VH反应0或0.5+是患者相关的结局。

研究设计与样本

  • 3期SAKURA研究1的事后分析,347例活动性非感染性后节葡萄膜炎受试者双盲随机接受玻璃体内注射西罗莫司44μg(n=117)、440μg(n=114)或880μg(n=116),每两月一次。
  • 采用主成分分析将多维视觉功能结局降维,基于测量标准误确定VFQ-25衍生组分的最小临床重要差异(MCID)。

主要发现

  • VFQ-25综合评分(VFQCS)和心理健康子量表评分(VFQMHS)被保留为相关视觉功能反应指标,MCID分别为4.3分和11.7分。
  • 玻璃体混浊反应与VFQCS改善显著相关(OR=2.23;P=0.0004)。
  • 玻璃体混浊反应与VFQMHS改善显著相关(OR=2.84;P<0.0001)。
  • 玻璃体混浊反应与BCVA改善显著相关(OR=2.60;P=0.0009),与总体视觉功能反应显著相关(OR=2.65;P<0.0001)。

关键数值与推荐

  • 玻璃体混浊反应定义为基于改良标准化葡萄膜炎命名量表第5个月VH评分0或0.5+。
  • 总体视觉功能反应定义为BCVA改善≥2行,或VFQ-25视觉功能指标改善超过MCID。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To examine the association between visual function response (VFR) and inflammation reduction in active noninfectious uveitis of the posterior segment (NIU-PS). METHODS: Phase 3 SAKURA Study 1 randomized 347 subjects in a double-masked fashion to receive injections of intravitreal sirolimus 44 μg (n = 117); 440 μg (n = 114); or 880 μg (n = 116) every other month. Vitreous haze (VH) response, a measure of inflammation reduction, was defined as a VH score of 0 or 0.5+ at month 5 based on the modified Standardized Uveitis Nomenclature Scale. Visual function was assessed with best-corrected visual acuity (BCVA) and the National Eye Institute (NEI) Visual Function Questionnaire-25 (VFQ-25). In this post-hoc analysis, principal component analysis was used to reduce the information in the multidimensional visual function outcome to a restricted number of independently relevant VFR measures. Minimal clinically important differences (MCID) for the VFQ-25-derived components were based on the standard error of measurements. Overall VFR was defined as either a BCVA improvement of ≥2 lines, or an improvement exceeding the MCID in the VFQ-25 based visual function measures. RESULTS: The VFQ-25 composite score (VFQCS) and mental health subscale score (VFQMHS) were retained as relevant VFRs, with MCIDs of 4.3 and 11.7 points, respectively. A vitreous haze response was significantly associated with each VFR measure: VFQCS (odds ratio [OR] = 2.23; P = 0.0004); VFQMHS (OR = 2.84; P < 0.0001); BCVA (OR = 2.60; P = 0.0009), and overall VFR (OR = 2.65; P < 0.0001). CONCLUSIONS: Inflammation reduction to a VH score of 0 or 0.5+ was significantly associated with improved visual function. Achieving a VH response of 0 or 0.5+ is a patient-relevant outcome.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Lescrauwaet B, Miserocchi E, Thurau S, et al. Association Between Visual Function Response and Reduction of Inflammation in Noninfectious Uveitis of the Posterior Segment. Invest Ophthalmol Vis Sci. 2017. PMID: 28715589. doi:10.1167/iovs.17-22049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。